Virologic rebound has also been reported in persons who did not receive nirmatrelvir therapy. However, studies that can define the frequencies of symptom and viral rebound during the natural course of COVID-19 are lacking.
Source link
Symptom and viral rebound rare after untreated COVID-19 infection: Study – ET HealthWorld
